Topical Finasteride and Minoxidil Explained

Topical finasteride is finasteride applied to the scalp as a spray, solution or foam, often combined with minoxidil, to treat male pattern hair loss. The FDA states that there is currently no FDA-approved topical finasteride, so US products are compounded and lack FDA-approved labeling.¹ In a European phase III trial, a topical finasteride spray grew more hair than placebo over 24 weeks.² Skin absorption still occurs, so a physician should explain the side effects and monitor you while you use it.¹

FDA Status of Topical Hair Solutions

Two finasteride products carry FDA approval, and both are tablets: Proscar for an enlarged prostate and Propecia for male pattern hair loss.¹ In its 2025 alert, the FDA states that there is no FDA-approved topical formulation of finasteride, alone or combined with other ingredients.¹

Compounded drugs are not FDA approved, which means the FDA has not evaluated their safety, effectiveness or quality before marketing.¹ The FDA notes that some compounders and telemedicine platforms sell topical finasteride alone or combined with minoxidil for hair loss.¹

Minoxidil has a different status. Topical minoxidil is sold over the counter to regrow hair on the top of the scalp.⁸ The minoxidil tablet label adds that custom topical preparations made from minoxidil "have not been shown to be safe or effective" and should be treated as carrying the full set of the tablet's warnings.⁷

A combined finasteride and minoxidil solution is a compounded product prescribed by a physician. You should know that status before you start, and your prescriber should tell you.

How Each Ingredient Works on the Scalp

The two ingredients are different medicines, and the FDA notes that some compounders combine them in one product.¹

Finasteride lowers DHT, and the finasteride page explains how. A 2018 systematic review found that topical finasteride lowered both scalp and blood DHT, with no change in serum testosterone.³

Minoxidil is a separate hair-growth medicine with its own over-the-counter label. Its labeled topical use is regrowth on the crown, and the Drug Facts label states that some men need at least four months of use to see results.⁸

Your physician decides whether you need one ingredient, both, or a tablet instead.

What the Trials Found

Topical finasteride alone. A phase III trial randomized 458 men at 45 European sites to topical finasteride spray, oral finasteride or placebo for 24 weeks.² Hair count rose by 20.2 hairs in the target area with the spray versus 6.7 with placebo.² The result was numerically similar to oral finasteride, and side effects did not differ meaningfully from placebo.² That trial tested one manufactured spray, so it does not prove that every compounded product performs the same way.

Finasteride and minoxidil combined. Three small randomized trials compared a combined topical with minoxidil alone.

• A 2018 double-blind trial in 40 men found the combined solution beat minoxidil alone on hair density, hair diameter and photographs at 24 weeks.⁴
• A 2024 three-arm pilot trial in 42 young men found the combination scored higher on global photographs than either ingredient alone, and raised hair density more than topical finasteride alone, over six months.⁵
• A 2024 single-blind trial in 164 men found response in 86.7% with the combination versus 69.1% with minoxidil alone at 12 weeks.⁶

These trials were short and small, and they used different formulations. They support the combination over minoxidil alone on the outcomes each trial measured, and long-term data are still limited.³ A 2025 Canadian expert consensus includes both topical finasteride and topical minoxidil among its seven recommended hair-loss treatments.¹⁰ Expect your physician to judge your own response on photographs over months.

Systemic Exposure and Sexual Side Effects

Topical finasteride still reaches your bloodstream, at lower levels than a tablet. In the European phase III trial, peak blood finasteride levels were more than 100 times lower with the spray than with the tablet.² Serum DHT fell 34.5% with the spray versus 55.6% with the tablet.² In the 2018 combination trial, plasma DHT fell about 5%.⁴

Lower exposure does not mean zero risk. The FDA states that skin absorption of finasteride "is expected."¹ Between 2019 and 2024, the FDA received 32 adverse event reports associated with compounded topical finasteride.¹ The reported effects matched those seen with oral finasteride, including erectile dysfunction, decreased libido, depression, anxiety, suicidal thoughts, brain fog, insomnia and testicular pain.¹ Most reports said the effects continued after the product was stopped.¹

The FDA also describes patients who were told a topical product carried no risk.¹ If a prescriber tells you that, ask for the full side-effect picture. Tell your physician promptly about any change in erections, libido or mood, so your plan can be adjusted early.

Other Cautions With Topical Treatment

Scalp reactions. The FDA lists irritation, redness, dryness or scaling, stinging and burning as local risks of topical finasteride.¹ Tell your physician if your scalp reacts, because the formulation or the plan can be changed.

Early shedding. A retrospective study of 49 patients using topical minoxidil found a temporary increase in hair shedding during the first 12 weeks.⁹ If you notice more hair in the drain early on, raise it with your physician before you stop.

Transfer to women. Finasteride can cause abnormalities of a male fetus, and approved tablets carry a coating that prevents contact during normal handling.¹ Compounded topical products have no coating, and the FDA warns of a greater risk of exposure to others, especially women, through transfer of applied product.¹ If you live with a partner who is or may become pregnant, discuss handling and contact with your physician before you start.

Heart history. The topical minoxidil label advises asking a doctor before use if you have heart disease.⁸ Mention any heart condition at your first consultation.

Topical and Oral Options Compared

You have three main routes for medicine-based hair-loss treatment: topical, oral, or a mix. Oral finasteride is FDA approved for hair loss in men, and the finasteride page covers it in detail.¹ Oral minoxidil is an off-label tablet option, since only topical minoxidil and oral finasteride are FDA approved for this condition.³ The finasteride vs minoxidil page compares the two ingredients directly.

A topical product suits you if you want lower blood levels of finasteride and are willing to apply it consistently.² A tablet suits you if daily application is hard to keep up. Your physician weighs your side-effect history, your household and your pattern of loss.

The Opt Take on Topical Finasteride

Topical finasteride is a compounded medicine with real side effects, so it belongs inside a supervised plan. The FDA recommends that health care providers educate patients on its risks, including transfer to women.¹ Every lab we order gets read by a physician before anyone is offered a treatment, and your existing conditions and current medications are reviewed at your initial consultation.

At Opt Health, you start with a 55+ biomarker panel and a 1:1 review with an Opt Health physician. If a topical solution or foam fits your plan, it ships from our pharmacy to your home. The hair loss protocol and male pattern baldness pages explain the wider approach. Labs and a physician consultation repeat every 3 to 4 months, so your physician can review your hair progress, ask about sexual function and mood, and adjust the plan.

Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.

Frequently Asked Questions

This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.